$DORM
Dorman Products, Inc.

2020 Q1 Form 10-Q Financial Statement

#000156459020018821 Filed on April 27, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2019 Q1
Revenue $257.7M $239.6M $243.8M
YoY Change 5.72% -7.98% 7.27%
Cost Of Revenue $172.9M $161.3M $156.3M
YoY Change 10.62% -1.29% 12.77%
Gross Profit $84.80M $78.30M $87.50M
YoY Change -3.09% -19.2% -1.24%
Gross Profit Margin 32.9% 32.68% 35.89%
Selling, General & Admin $59.70M $56.30M $57.75M
YoY Change 3.38% 7.65% 18.83%
% of Gross Profit 70.4% 71.9% 66.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.500M $4.900M $7.300M
YoY Change 2.74% -43.68% 14.06%
% of Gross Profit 8.84% 6.26% 8.34%
Operating Expenses $59.80M $56.40M $57.75M
YoY Change 3.55% 7.84% 18.58%
Operating Profit $25.06M $21.90M $29.74M
YoY Change -15.74% -50.94% -25.63%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $2.631M -$100.0K $29.00K
YoY Change 8972.41% -66.67% -80.92%
Pretax Income $27.69M $21.80M $29.77M
YoY Change -6.98% -50.79% -25.76%
Income Tax $4.918M $4.200M $6.364M
% Of Pretax Income 17.76% 19.27% 21.38%
Net Earnings $22.78M $17.55M $23.41M
YoY Change -2.7% -49.28% -23.62%
Net Earnings / Revenue 8.84% 7.32% 9.6%
Basic Earnings Per Share $0.70 $0.71
Diluted Earnings Per Share $0.70 $0.54 $0.71
COMMON SHARES
Basic Shares Outstanding 32.35M 32.80M
Diluted Shares Outstanding 32.43M 32.89M

Balance Sheet

Concept 2020 Q1 2019 Q4 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $161.8M $68.40M $40.80M
YoY Change 296.57% 57.24% -45.82%
Cash & Equivalents $161.8M $68.35M $40.79M
Short-Term Investments
Other Short-Term Assets $10.80M $13.60M $7.400M
YoY Change 45.95% 138.6% -13.95%
Inventory $258.4M $280.8M $288.9M
Prepaid Expenses
Receivables $423.3M $391.8M $297.5M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $854.3M $754.6M $634.6M
YoY Change 34.62% 4.76% 17.43%
LONG-TERM ASSETS
Property, Plant & Equipment $99.08M $101.8M $101.4M
YoY Change -2.28% 3.23% 9.23%
Goodwill $91.28M $74.46M $72.60M
YoY Change 25.72% 2.55% 10.15%
Intangibles $27.75M $21.31M $24.66M
YoY Change 12.51% -15.34% 13.38%
Long-Term Investments $19.30M
YoY Change 4.89%
Other Assets $44.30M $52.35M $53.20M
YoY Change -16.72% -5.14% 17.15%
Total Long-Term Assets $298.5M $286.5M $292.9M
YoY Change 1.92% 11.11% 25.89%
TOTAL ASSETS
Total Short-Term Assets $854.3M $754.6M $634.6M
Total Long-Term Assets $298.5M $286.5M $292.9M
Total Assets $1.153B $1.041B $927.5M
YoY Change 24.29% 6.44% 19.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $73.28M $90.44M $98.28M
YoY Change -25.44% -17.1% 55.74%
Accrued Expenses $142.3M $14.38M $29.36M
YoY Change 384.64% 23.53% 9.58%
Deferred Revenue
YoY Change
Short-Term Debt $99.00M $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $314.5M $220.5M $133.9M
YoY Change 134.88% -5.01% 39.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $13.30M $13.30M $14.21M
YoY Change -6.42% -1.87% 4.09%
Total Long-Term Liabilities $13.30M $13.30M $14.21M
YoY Change -6.42% -1.87% 4.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $314.5M $220.5M $133.9M
Total Long-Term Liabilities $13.30M $13.30M $14.21M
Total Liabilities $327.8M $233.8M $148.1M
YoY Change 121.32% -4.84% 35.29%
SHAREHOLDERS EQUITY
Retained Earnings $737.6M $720.7M $691.5M
YoY Change 6.67% 6.07% 13.11%
Common Stock $53.78M $52.93M $50.22M
YoY Change 7.09% 9.84% 9.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $791.4M $773.6M $741.7M
YoY Change
Total Liabilities & Shareholders Equity $1.153B $1.041B $927.5M
YoY Change 24.29% 6.44% 19.98%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2019 Q1
OPERATING ACTIVITIES
Net Income $22.78M $17.55M $23.41M
YoY Change -2.7% -49.28% -23.62%
Depreciation, Depletion And Amortization $7.500M $4.900M $7.300M
YoY Change 2.74% -43.68% 14.06%
Cash From Operating Activities $18.59M $35.60M $16.43M
YoY Change 13.14% 175.97% -16.81%
INVESTING ACTIVITIES
Capital Expenditures $3.505M -$4.900M $8.838M
YoY Change -60.34% -38.75% 40.82%
Acquisitions $14.46M
YoY Change
Other Investing Activities -$14.50M $0.00
YoY Change -100.0%
Cash From Investing Activities -$17.97M -$4.900M -$8.838M
YoY Change 103.29% -62.31% 40.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 92.80M -16.60M -10.26M
YoY Change -1004.77% 78.49% 4.97%
NET CHANGE
Cash From Operating Activities 18.59M 35.60M 16.43M
Cash From Investing Activities -17.97M -4.900M -8.838M
Cash From Financing Activities 92.80M -16.60M -10.26M
Net Change In Cash 93.43M 14.10M -2.664M
YoY Change -3606.94% -250.0% -172.93%
FREE CASH FLOW
Cash From Operating Activities $18.59M $35.60M $16.43M
Capital Expenditures $3.505M -$4.900M $8.838M
Free Cash Flow $15.09M $40.50M $7.593M
YoY Change 98.67% 93.78% -43.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
22775000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
57750000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
25062000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
29742000
CY2020Q1 us-gaap Inventory Net
InventoryNet
258371000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10810000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
854260000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
99082000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32230000
CY2020Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3886000
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y1M28D
CY2020Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherAccruedLiabilitiesCurrent
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M6D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y4M24D
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32354000
CY2019Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4336000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1214000
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
5780000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-418000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
22775000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
791375000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
727623000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
31000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-634000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
23407000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
741707000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
22775000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
23407000
CY2020Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
7496000
CY2019Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
7265000
CY2020Q1 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
2498000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
14000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-912000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1214000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
915000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
29491000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13333000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-28016000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18184000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2262000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3685000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2219000
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1925000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-19346000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-11091000
CY2020Q1 dorm Increase Decrease In Accrued Customer Rebates And Returns
IncreaseDecreaseInAccruedCustomerRebatesAndReturns
4471000
CY2019Q1 dorm Increase Decrease In Accrued Customer Rebates And Returns
IncreaseDecreaseInAccruedCustomerRebatesAndReturns
-497000
CY2020Q1 dorm Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
6808000
CY2019Q1 dorm Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
3043000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18590000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32801000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32426000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68353000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27693000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4918000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6364000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
23407000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2631000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
29000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29771000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32889000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161778000
CY2020Q1 us-gaap Goodwill
Goodwill
91275000
CY2020Q1 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
1063000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
423301000
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
27748000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29714000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
791375000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1152784000
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9339000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
314537000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32558168
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21305000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32558168
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
326000
CY2019Q4 dorm Accrued Customer Rebates And Returns
AccruedCustomerRebatesAndReturns
105903000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9782000
CY2020Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
99000000
CY2020Q1 dorm Accrued Customer Rebates And Returns
AccruedCustomerRebatesAndReturns
110374000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
737596000
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
22541000
CY2019Q4 us-gaap Inventory Net
InventoryNet
280813000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14380000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
325000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
53454000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
391810000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44303000
CY2020Q1 us-gaap Assets
Assets
1152784000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13614000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
52605000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
754590000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101837000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32198000
CY2019Q4 us-gaap Goodwill
Goodwill
74458000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
52348000
CY2019Q4 us-gaap Assets
Assets
1041072000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
73283000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
90437000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1041072000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16431000
CY2019Q1 dorm Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
3043000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32434665
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32434665
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2631000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
29000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2019Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
957000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
22775000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
23407000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
220502000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29730000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13298000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13297000
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3860000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3959000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
720653000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
773584000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
773584000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
915000
CY2019Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
9635000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16431000
CY2020Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14462000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17967000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8838000
CY2020Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
99000000
CY2020Q1 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-418000
CY2019Q1 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-622000
CY2020Q1 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
5780000
CY2019Q1 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
9635000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
92802000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10257000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
93425000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2664000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
68353000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43458000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
161778000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
40794000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
20000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
61000
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
74000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13333000
CY2019Q1 dorm Increase Decrease In Accrued Customer Rebates And Returns
IncreaseDecreaseInAccruedCustomerRebatesAndReturns
-497000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
241880000
CY2017Q4 dorm Accrued Customer Rebates And Returns
AccruedCustomerRebatesAndReturns
6522000
CY2020Q1 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
151300000
CY2019Q1 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
172800000
CY2020Q1 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
375700000
CY2019Q4 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
437900000
CY2020Q1 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
2800000
CY2019Q1 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
4600000
CY2020Q1 dorm Maximum Credit Terms Allow To Customers
MaximumCreditTermsAllowToCustomers
P1Y
CY2019Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
114308000
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
152632000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
161866000
CY2020Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
4621000
CY2020Q1 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
101118000
CY2019Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
4639000
CY2020Q1 us-gaap Inventory Net
InventoryNet
258371000
CY2019Q4 us-gaap Inventory Net
InventoryNet
280813000
CY2020Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1900000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1200000
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1901000
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1928000
CY2020Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1114000
CY2019Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1070000
CY2020Q1 us-gaap Lease Cost
LeaseCost
3015000
CY2019Q1 us-gaap Lease Cost
LeaseCost
2998000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32230000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5412000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29714000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
35126000
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0518
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4357000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5476000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5004000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3388000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3451000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
21514000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
43190000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8064000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
35126000
CY2019Q4 us-gaap Goodwill
Goodwill
74458000
CY2018Q4 us-gaap Goodwill
Goodwill
72606000
CY2020Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
16817000
CY2019 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
1852000
CY2020Q1 us-gaap Goodwill
Goodwill
91275000
CY2019Q4 us-gaap Goodwill
Goodwill
74458000
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34407000
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6659000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
65.13
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
27748000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
27117000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5812000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21305000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000
CY2020Q1 dorm Number Of Outstanding Letters Of Credit
NumberOfOutstandingLettersOfCredit
2
CY2019 dorm Estimated Underpayments Of Duties Amount
EstimatedUnderpaymentsOfDutiesAmount
2800000
CY2020Q1 dorm Maximum Credit Terms Allow To Customers
MaximumCreditTermsAllowToCustomers
P1Y
CY2020Q1 us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
A receivable is recorded when our right to consideration is unconditional and only the passage of time is required before payment of that consideration is due.
CY2020Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
257730000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243791000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
257730000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243791000
CY2020Q1 dorm Date Of Plan Approval
DateOfPlanApproval
2018-05-16
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1200000
CY2020Q1 dorm Maximum Grant Period From Date Of Plan Approval
MaximumGrantPeriodFromDateOfPlanApproval
P10Y
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
885847
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
177491
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
76.70
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
72369
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
61.68
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
14399
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
22488
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
78.67
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
212973
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
72.17
CY2020Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
200000
CY2019Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
200000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
181712
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
70.78
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
280267
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
67.63
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
98974
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
61.86
CY2020Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
419
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
72.55
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
265750
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
96386
CY2020Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
65.15
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
265750
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
91273
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
114000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
22775000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
23407000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32354000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32801000
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
72000
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
88000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32426000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32889000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
4730
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
300000
CY2020Q1 dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
66.66
CY2019 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
22380
CY2019 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1900000
CY2019 dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
87.26
CY2020Q1 us-gaap Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2020-12-31
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1600000
CY2020Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2022-12-31
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2300000
CY2020Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2000000.0
CY2020Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
400000

Files In Submission

Name View Source Status
0001564590-20-018821-index-headers.html Edgar Link pending
0001564590-20-018821-index.html Edgar Link pending
0001564590-20-018821.txt Edgar Link pending
0001564590-20-018821-xbrl.zip Edgar Link pending
dorm-10q_20200328.htm Edgar Link pending
dorm-10q_20200328_htm.xml Edgar Link completed
dorm-20200328.xsd Edgar Link pending
dorm-20200328_cal.xml Edgar Link unprocessable
dorm-20200328_def.xml Edgar Link unprocessable
dorm-20200328_lab.xml Edgar Link unprocessable
dorm-20200328_pre.xml Edgar Link unprocessable
dorm-ex311_7.htm Edgar Link pending
dorm-ex312_8.htm Edgar Link pending
dorm-ex32_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g0a232zgxubn000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending